How do you see the Gland Pharma stock after the quarterly results?
Answer
Answer
Gland Pharma net profits were higher by 34% at Rs.260 crore in the Mar-21 quarter on the back of robust sales growth. Total revenues for the quarter came in 40% higher at Rs.888 crore in the Mar-21 quarter.
The vaccine vertical is anticipated to boost the prospects of Gland Pharma entering into the Biosimilar space. Gland Pharma had recently listed with its Rs.6,000 crore IPO.